Alternativen zu Antibiotika in der Parodontologie

Immer noch sehr häufig werden Antibiotika in der Behandlung von Parodontitis eingesetzt. Jedoch wird deren Anwendung aufgrund der Nebenwirkungen zunehmend kritisch hinterfragt. Vor allem, da die Parodontitis nicht unmittelbar lebensbedrohend ist, steht die Frage nach Alternativen im Raum. Obwohl viele Alternativen mittlerweile Gegenstand von Forschung sind, gibt es nach aktuellen klinischen Empfehlungen bisher keine Evidenz für deren Einsatz.

Schlüsselwörter

Instrumentierung - Antibiotika - Naturprodukte - Parodontitistherapie

• Literatur

• 1 Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 2022; 399: 629-655
• 2 Lindhe J, Liljenberg B, Adielson B. et al. Use of metronidazole as a probe in the study of human periodontal disease. J Clin Periodontol 1983; 10: 100-112
• 3 Sgolastra F, Petrucci A, Ciarrocchi I. et al. Adjunctive systemic antimicrobials in the treatment of chronic periodontitis: A systematic review and network meta-analysis. J Periodontal Res 2021; 56: 236-248
• 4 Wang CY, Yang YH, Li H. et al. Adjunctive local treatments for patients with residual pockets during supportive periodontal care: A systematic review and network meta-analysis. J Clin Periodontol 2020; 47: 1496-1510
• 5 Zaura-Arite E, van Marle J, ten Cate JM. Conofocal microscopy study of undisturbed and chlorhexidine-treated dental biofilm. J Dent Res 2001; 80: 1436-1440
• 6 Stähli A, Schröter H, Bullitta S. et al. In Vitro Activity of Propolis on Oral Microorganisms and Biofilms. Antibiotics (Basel) 2021; 10: 1045
• 7 de Figueiredo KA, da Silva HDP, Miranda SLF. et al. Brazilian Red Propolis Is as Effective as Amoxicillin in Controlling Red-Complex of Multispecies Subgingival Mature Biofilm In Vitro. Antibiotics (Basel) 2020; 9: 432
• 8 Li Y, Jiao J, Qi Y. et al. Curcumin: A review of experimental studies and mechanisms related to periodontitis treatment. J Periodontal Res 2021; 56: 837-847
• 9 Bassetti M, Schär D, Wicki B. et al. Anti-infective therapy of peri-implantitis with adjunctive local drug delivery or photodynamic therapy: 12-month outcomes of a randomized controlled clinical trial. Clin Oral Implants Res 2014; 25: 279-287
• 10 Taalab MR, Mahmoud SA, Moslemany RME. et al. Intrapocket application of tea tree oil gel in the treatment of stage 2 periodontitis. BMC Oral Health 2021; 21: 239
• 11 Sabbagh MN, Decourt B. COR388 (atuzaginstat): an investigational gingipain inhibitor for the treatment of Alzheimer disease. Expert Opin Investig Drugs 2022; 31: 987-993
• 12 Taudte N, Linnert M, Rahfeld JU. et al. Mammalian-like type II glutaminyl cyclases in Porphyromonas gingivalis and other oral pathogenic bacteria as targets for treatment of periodontitis. J Biol Chem 2021; 296: 100263
• 13 Zhao Y, Pu R, Qian Y. et al. Antimicrobial photodynamic therapy versus antibiotics as an adjunct in the treatment of periodontitis and peri-implantitis: A systematic review and meta-analysis. Photodiagnosis Photodyn Ther 2021; 34: 102231
• 14 Küçük D, Savran L, Ercan UK. et al. Evaluation of efficacy of non-thermal atmospheric pressure plasma in treatment of periodontitis: a randomized controlled clinical trial. Clin Oral Investig 2020; 24: 3133-3145
• 15 Villafuerte KRV, Martinez CJH, Nobre AVV. et al. What are microbiological effects of the adjunctive use of probiotics in the treatment of periodontal diseases? A systematic review. Benef Microbes 2021; 12: 1-13
• 16 Sanz M, Herrera D, Kebschull M. et al. Treatment of stage I–III periodontitis-The EFP S3 level clinical practice guideline. J Clin Periodontol 2020; 47 (Suppl. 22) 4-60
• 17 Jurczyk K, Nietzsche S, Ender C. et al. In-vitro activity of sodium-hypochlorite gel on bacteria associated with periodontitis. Clin Oral Investig 2016; 20: 2165-2173
• 18 Iorio-Siciliano V, Ramaglia L, Isola G. et al. Changes in clinical parameters following adjunctive local sodium hypochlorite gel in minimally invasive nonsurgical therapy (MINST) of periodontal pockets: a 6-month randomized controlled clinical trial. Clin Oral Investig 2021; 25: 5331-5340
• 19 Anonymous, Deutsche Gesellschaft für Parodontologie e. V. (federführend).. Die Behandlung von Parodontitis Stadium I bis III. Die deutsche Implementierung der S3-Leitlinie „Treatment of Stage I–III Periodontitis“ der European Federation of Periodontology (EFP). AWMF-Registriernummer 083–043, gültig bis November 2025. 2021 Accessed November 02, 2021 at: https://register.awmf.org/assets/guidelines/083–043l_S3_Behandlung-von-Parodontitis-Stadium-I-III_2021–02_2.pdf